Phenotypic modulation of arterial smooth muscle cells is associated with prolonged activation of ERK1/2
- 1 February 2001
- journal article
- Published by Elsevier in Differentiation
- Vol. 67 (1-2) , 50-58
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Integrin SignalingScience, 1999
- Tyrphostin A9 and wortmannin perturb the Golgi complex and block proliferation of vascular smooth muscle cellsEuropean Journal of Cell Biology, 1998
- Disruption of integrin α5β1 signaling does not impair PDGF-BB-mediated stimulation of the extracellular signal-regulated kinase pathway in smooth muscle cellsJournal of Cellular Physiology, 1997
- Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation.Journal of Clinical Investigation, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- cPLA2 is phosphorylated and activated by MAP kinaseCell, 1993
- Integrin-type fibronectin receptors of rat arterial smooth muscle cells: isolation, partial characterization and role in cytoskeletal organization and control of differentiated propertiesDifferentiation, 1989
- A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotypeDevelopmental Biology, 1989
- Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens.Journal of Cell Biology, 1981